C
Cellivery Therapeutics Inc
KOSDAQ:268600
Cellivery Therapeutics Inc
KOSDAQ:268600
Price:
6 680
KRW
-29.91%
Market Closed
Market Cap:
₩594.9m
Income Statement
Earnings Waterfall
Cellivery Therapeutics Inc
Cellivery Therapeutics Inc
Income Statement
Cellivery Therapeutics Inc
Cellivery Therapeutics Inc
Currency: KRW
| Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||||||||||
| Interest Expense |
1 795
|
1 178
|
427
|
0
|
0
|
(0)
|
2
|
257
|
765
|
1 279
|
1 813
|
1 981
|
2 661
|
3 451
|
4 311
|
5 486
|
6 439
|
5 753
|
0
|
3 384
|
5 186
|
3 761
|
0
|
3 288
|
|
| Revenue |
4 512
N/A
|
3 539
-22%
|
2 461
-30%
|
2 717
+10%
|
2 074
-24%
|
1 776
-14%
|
1 197
-33%
|
917
-23%
|
762
-17%
|
679
-11%
|
455
-33%
|
367
-19%
|
3 872
+954%
|
11 896
+207%
|
16 604
+40%
|
21 276
+28%
|
23 158
+9%
|
15 871
-31%
|
11 926
-25%
|
7 262
-39%
|
18 863
+160%
|
21 998
+17%
|
22 685
+3%
|
24 536
+8%
|
|
| Gross Profit | |||||||||||||||||||||||||
| Cost of Revenue |
(2 996)
|
(2 881)
|
(3 372)
|
(3 022)
|
(3 976)
|
(3 668)
|
(3 184)
|
(2 831)
|
(1 485)
|
(1 287)
|
(834)
|
(472)
|
(3 802)
|
(10 464)
|
(14 615)
|
(19 132)
|
(23 427)
|
(17 566)
|
(14 211)
|
(10 507)
|
(18 673)
|
(21 994)
|
(22 437)
|
(23 972)
|
|
| Gross Profit |
1 517
N/A
|
658
-57%
|
(911)
N/A
|
(305)
+66%
|
(1 902)
-523%
|
(1 892)
+1%
|
(1 987)
-5%
|
(1 914)
+4%
|
(724)
+62%
|
(608)
+16%
|
(380)
+37%
|
(105)
+72%
|
71
N/A
|
1 432
+1 927%
|
1 989
+39%
|
2 144
+8%
|
(269)
N/A
|
(1 695)
-530%
|
(2 285)
-35%
|
(3 245)
-42%
|
190
N/A
|
4
-98%
|
249
+6 226%
|
564
+127%
|
|
| Operating Income | |||||||||||||||||||||||||
| Operating Expenses |
(5 619)
|
(2 185)
|
(6 170)
|
(10 956)
|
(12 682)
|
(13 577)
|
(14 596)
|
(15 464)
|
(16 888)
|
(17 567)
|
(19 954)
|
(24 011)
|
(28 121)
|
(40 452)
|
(46 139)
|
(53 404)
|
(66 623)
|
(55 994)
|
(50 779)
|
(35 947)
|
(19 757)
|
(21 751)
|
(18 578)
|
(15 495)
|
|
| Selling, General & Administrative |
(4 703)
|
(5 246)
|
(6 256)
|
(7 397)
|
(7 734)
|
(8 414)
|
(8 147)
|
(8 802)
|
(10 300)
|
(10 955)
|
(14 555)
|
(16 184)
|
(18 993)
|
(29 234)
|
(33 983)
|
(40 859)
|
(43 274)
|
(32 944)
|
(22 897)
|
(12 532)
|
(8 848)
|
(10 715)
|
(11 686)
|
(11 364)
|
|
| Research & Development |
(410)
|
(691)
|
(1 997)
|
(2 800)
|
(3 975)
|
(4 240)
|
(5 530)
|
(5 772)
|
(5 697)
|
(5 678)
|
(4 387)
|
(6 727)
|
(7 708)
|
(9 273)
|
(9 505)
|
(9 098)
|
(19 115)
|
(19 586)
|
(23 725)
|
0
|
(6 946)
|
(7 695)
|
0
|
(2 078)
|
|
| Depreciation & Amortization |
(506)
|
(671)
|
(757)
|
(878)
|
(973)
|
(922)
|
(918)
|
(890)
|
(891)
|
(933)
|
(1 012)
|
(1 100)
|
(1 343)
|
(1 947)
|
(2 651)
|
(3 447)
|
(3 782)
|
(3 465)
|
(4 157)
|
(3 512)
|
(3 512)
|
(4 036)
|
0
|
(1 931)
|
|
| Other Operating Expenses |
0
|
4 423
|
2 840
|
119
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(76)
|
0
|
0
|
0
|
(452)
|
0
|
0
|
(19 903)
|
(451)
|
695
|
(6 892)
|
(122)
|
|
| Operating Income |
(4 103)
N/A
|
(1 527)
+63%
|
(7 080)
-364%
|
(11 261)
-59%
|
(14 584)
-30%
|
(15 469)
-6%
|
(16 583)
-7%
|
(17 378)
-5%
|
(17 612)
-1%
|
(18 174)
-3%
|
(20 334)
-12%
|
(24 116)
-19%
|
(28 050)
-16%
|
(39 020)
-39%
|
(44 150)
-13%
|
(51 260)
-16%
|
(66 892)
-30%
|
(57 689)
+14%
|
(53 064)
+8%
|
(39 191)
+26%
|
(19 568)
+50%
|
(21 747)
-11%
|
(18 329)
+16%
|
(14 931)
+19%
|
|
| Pre-Tax Income | |||||||||||||||||||||||||
| Interest Income Expense |
(6 975)
|
(11 821)
|
(9 533)
|
(9 150)
|
(4 981)
|
579
|
554
|
174
|
(291)
|
(788)
|
(1 325)
|
(1 529)
|
(1 741)
|
(2 742)
|
(6 151)
|
(7 887)
|
(5 175)
|
(4 207)
|
(1 754)
|
(253)
|
(4 631)
|
(5 260)
|
(4 741)
|
(4 293)
|
|
| Non-Reccuring Items |
4 423
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
0
|
(45)
|
(36)
|
(3 361)
|
(5 321)
|
(10 856)
|
(10 899)
|
(8 781)
|
(8 735)
|
0
|
(2 961)
|
|
| Gain/Loss on Disposition of Assets |
3
|
(2)
|
(2)
|
0
|
(5)
|
0
|
21
|
10
|
(11)
|
0
|
0
|
(41)
|
(14)
|
100
|
70
|
0
|
85
|
(361)
|
(1 228)
|
(1 139)
|
(2 207)
|
(2 348)
|
0
|
(1 558)
|
|
| Total Other Income |
0
|
(6)
|
(7)
|
(10)
|
(7)
|
(0)
|
3
|
3
|
(23)
|
(38)
|
(63)
|
(34)
|
122
|
131
|
142
|
3 019
|
324
|
320
|
311
|
(2 831)
|
1 181
|
1 188
|
209
|
1 854
|
|
| Pre-Tax Income |
(6 651)
N/A
|
(13 356)
-101%
|
(16 623)
-24%
|
(20 421)
-23%
|
(19 577)
+4%
|
(14 891)
+24%
|
(16 005)
-7%
|
(17 190)
-7%
|
(17 937)
-4%
|
(19 000)
-6%
|
(21 721)
-14%
|
(25 719)
-18%
|
(29 682)
-15%
|
(41 532)
-40%
|
(50 134)
-21%
|
(56 164)
-12%
|
(75 018)
-34%
|
(67 258)
+10%
|
(66 590)
+1%
|
(54 314)
+18%
|
(34 007)
+37%
|
(36 901)
-9%
|
(22 861)
+38%
|
(21 889)
+4%
|
|
| Net Income | |||||||||||||||||||||||||
| Tax Provision |
(47)
|
(47)
|
(47)
|
(47)
|
(73)
|
(73)
|
(73)
|
(73)
|
688
|
0
|
688
|
688
|
1 613
|
1 638
|
1 572
|
1 597
|
(141)
|
(194)
|
(157)
|
0
|
(29)
|
(29)
|
(0)
|
0
|
|
| Income from Continuing Operations |
(6 698)
|
(13 403)
|
(16 670)
|
(20 468)
|
(19 650)
|
(14 964)
|
(16 078)
|
(17 263)
|
(17 248)
|
(18 312)
|
(21 033)
|
(25 031)
|
(28 069)
|
(39 894)
|
(48 561)
|
(54 567)
|
(75 159)
|
(67 452)
|
(66 748)
|
(54 496)
|
(34 036)
|
(36 930)
|
(22 862)
|
(21 890)
|
|
| Income to Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1 465
|
1 633
|
1 735
|
1 940
|
|
| Net Income (Common) |
(6 698)
N/A
|
(13 403)
-100%
|
(16 670)
-24%
|
(20 468)
-23%
|
(19 650)
+4%
|
(14 964)
+24%
|
(16 078)
-7%
|
(17 263)
-7%
|
(17 248)
+0%
|
(18 312)
-6%
|
(21 033)
-15%
|
(25 031)
-19%
|
(28 069)
-12%
|
(39 894)
-42%
|
(48 561)
-22%
|
(54 567)
-12%
|
(75 159)
-38%
|
(73 151)
+3%
|
(84 845)
-16%
|
(74 018)
+13%
|
(32 571)
+56%
|
(35 297)
-8%
|
(8 729)
+75%
|
(6 127)
+30%
|
|
| EPS (Diluted) |
-650.33
N/A
|
-881.79
-36%
|
-1 035.39
-17%
|
-1 312.01
-27%
|
-1 267.74
+3%
|
-935.21
+26%
|
-913.53
+2%
|
-1 003.65
-10%
|
-1 071.32
-7%
|
-1 592.34
-49%
|
-631.2
+60%
|
-738.8
-17%
|
-833.92
-13%
|
-1 150.74
-38%
|
-1 400.76
-22%
|
-1 568.96
-12%
|
-2 984.97
-90%
|
-1 997.42
+33%
|
-2 315.76
-16%
|
-2 018.6
+13%
|
-889.35
+56%
|
-962.62
-8%
|
-237.46
+75%
|
-163.8
+31%
|
|
Switch to:
Switch to:
See Also
Discover More
